ViewRay Systems, Inc. Stock

Stocks

Market Closed - OTC Markets 03:06:43 12/09/26 am AEST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

13/01	Outset Medical, Inc. Announces Board Changes	CI
03/12	Cowealth Medical China Unit to Sell Therapy System to Connected Party in Taiwan	MT

13/01	Outset Medical, Inc. Announces Board Changes	CI
03/12	Cowealth Medical China Unit to Sell Therapy System to Connected Party in Taiwan	MT
12/03/24	Cowealth Medical China Gets Business Authorization for ViewRay Systems' Products	MT
26/10/23	Motion For Case Conversion Approved for ViewRay, Inc.	CI
12/10/23	Motion for Case Conversion Filed by ViewRay, Inc.	CI
29/08/23	Final DIP Financing Approved for ViewRay, Inc.	CI
23/08/23	Bidding Procedure Approved for ViewRay, Inc.	CI
04/08/23	On August 3, 2023, Viewray, Inc. Relocates Its Headquarters to Oakwood Village, Ohio	CI
25/07/23	ViewRay, Inc.(OTCPK:VRAY.Q) dropped from NASDAQ Composite Index	CI
22/07/23	ViewRay to be Delisted From Nasdaq July 26	MT
22/07/23	Insider Sell: Viewray	MT
22/07/23	ViewRay, Inc. Announces the Resignation of Sai Nanduri as Observer to the Board	CI
21/07/23	Motion for Asset Sale Filed by ViewRay, Inc.	CI

12/05/23	Morgan Stanley Adjusts ViewRay's Price Target to $1 From $2, Keeps Equalweight Rating	MT
11/05/23	B. Riley Downgrades ViewRay to Neutral From Buy, Notes More Cautious, Conservative 2023 Outlook; Trims PT to $1 From $4	MT
25/04/23	Piper Sandler Cuts Price Target on ViewRay to $2 From $6.50, Maintains Overweight Rating	MT
17/04/23	Jefferies Downgrades ViewRay to Hold From Buy, Cuts Price Target to $1.25 From $7	MT
14/04/23	Oppenheimer Downgrades ViewRay to Perform Rating From Outperform	MT

16/10/23	TeamBest Global Companies - Open Letter to ViewRay Customers From Krishnan Suthanthiran, President/Founder of TeamBest Global Companies	AQ
22/07/23	ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets	PR
17/07/23	ViewRay® Files Voluntary Chapter 11 Petitions	PR
01/07/23	ViewRay : Failure to Satisfy Listing Rule - Form 8-K	PU
13/06/23	VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System	PR

Manager	Title	Age	Since
Samantha Pfeil SAM	Sales & Marketing	-	01/04/2021
Amanda Sequira LAW	General Counsel	49	01/10/2018

Date	Insider	Type	Main position	Quantity	% Market Cap.
21/7/23	B. Johnson	Sell	Director	30,702	0.0167%
19/7/23	Kearny Venture Partners	Sell	Company	1,545,600	0.8427%
19/7/23	Karen Prange	Sell	Director	129,466	0.0706%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIEWRAY SYSTEMS, INC.	0.00%	0.00%	-	-	183
CHURCHILL CAPITAL CORP XI	-3.83%	-8.06%	-	-	686M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.07%	-0.07%	-	-	647M
BAIN CAPITAL GSS INVESTMENT CORP.	-0.10%	-0.24%	-	-	601M
CHURCHILL CAPITAL CORP XII	+0.46%	+0.65%	-	-	599M
CANTOR EQUITY PARTNERS IV, INC.	0.00%	-0.43%	+1.87%	-	592M
CENTIEL AG	+1.75%	+3.93%	+257.49%	-78.60%	582M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.70%	-0.96%	-	-	559M
CHURCHILL CAPITAL CORP XIII	+0.76%	+0.66%	-	-	513M
Average	-0.19%	-0.50%	+129.68%	-78.60%	530.97M
Weighted average by Cap.	-0.30%	-0.73%	+128.63%	-78.60%